Skip to main content

Table 1 Participant demographics round 1–3

From: A modified Delphi study to identify screening items to assess neglected sexual side-effects following prostate cancer treatment

Participant demographics Round 1 Round 2 Round 3
Number 27 23 20
Age    
31–40 5 (19%) 3 (13%) 2 (10%)
41–50 11 (41%) 9 (39%) 8 (40%)
51–60 8 (30% 8 (35%) 8 (40%)
 > 61 3 (11%) 3 (13%) 2 (10%)
Gender    
Male 13 (48%) 11 (48%) 9 (45%)
Female 14 (52%) 12 (52%) 11 (55%)
Profession    
Oncologist 4 (15%) 3 (13%) 2 (10%)
Physiotherapist 6 (22%) 5 (22%) 5 (25%)
Psychologist 2 (7%) 2 (9%) 2 (10%)
Sexologist (with a medical background i.e. a GP) 3 (11%) 3 (13%) 2 (10%)
Sexologist (with a psychology background) 4 (15%) 4 (17%) 4 (20%)
Urologist (involved in brachytherapy/radiation therapy) 3 (11%) 2 (9%) 2 (10%)
Urologist (performing radical prostatectomies) 5 (19%) 4 (17%) 3 (15%)
Highest academic qualification    
Bachelor’s degree 3 (11%) 2 (9%) 2 (10%)
Honours degree 3 (11%) 2 (9%) 2 (10%)
Master’s degree 15 (56%) 13 (57%) 11 (55%)
PhD 6 (22%) 6 (26%) 5 (25%)
Health sector    
Government 1 (4%) 1 (4%) 1 (5%)
Private 20 (74%) 17 (74%) 15 (75%)
Private, govt and academic 2 (7%) 2 (9%) 2 (10%)
Private and academic 4 (15%) 3 (13%) 2 (10%
Years of experience    
 < 5 years 1 (4%)   
5–10 years 4 (15%) 4 (17%) 3 (15%)
11–15 years 4 (15%) 4 (17%) 3 (15%)
16–20 years 6 (22%) 3 (13%) 3 (15%)
 > 20 years 12 (44%) 12 (52%) 11 (55%)